Nasdaq · CIK 0002114044
COAG Hemab Therapeutics Holdings, Inc.
Insider trading from SEC Form 4. Last filing 18 d ago.
Hemab Therapeutics Holdings, Inc. (COAG) has 2 SEC Form 4 filings on file from 2 insiders, the latest filed on Sep 25, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Hemab Therapeutics Holdings, Inc., scored.
Transactions
Every row filed, 3 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Keli Walbert director | AGrant or award Stock Option (Right to Buy)derivative | +36,000 | $0.00 | $0 | 36,000 | 18 d ago |
| Jan 29, 2026 | Mads Nikolaj Behrndt-Eriksen See Remarks | AGrant or award Warrants (Right to Buy)derivative | +195,206 | $0.00 | $0 | 195,206 | May 4, 2026 |
| Apr 30, 2026 | Mads Nikolaj Behrndt-Eriksen See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +49,016 | $0.00 | $0 | 49,016 | May 4, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Mads Nikolaj Behrndt-EriksenSee Remarks
- Keli Walbertdirector
Questions about COAG
Answered from the filings on this page, as of the latest one.
Are insiders buying COAG?
No. In the last 90 days no insider at Hemab Therapeutics Holdings, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade COAG on the open market?
No open-market trade has been scored at Hemab Therapeutics Holdings, Inc.. The latest Form 4 on file was filed on Sep 25, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Hemab Therapeutics Holdings, Inc.?
2 people have filed a Form 4 at Hemab Therapeutics Holdings, Inc., among them Mads Nikolaj Behrndt-Eriksen (See Remarks), Keli Walbert (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.